JANUARY 17, 2022

Largest Data Set Yet Confirms Efficacy of mRNA Vaccines in IBD Patients

Over 95% of inflammatory bowel disease patients who receive two doses of a messenger RNA (mRNA)-based SARS-CoV-2 vaccine develop detectable antibody levels, according to findings from the largest data set on the topic to date.

However, the results, which were presented at the 2021 annual meeting of the American College of Gastroenterology (oral abstract 3), showed treatment with corticosteroids significantly reduced antibody levels while combination treatment with an anti–tumor necrosis